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Abstract
Kainate receptors (KARs) are glutamate-gated ion channels that play fundamental roles in regulating neuronal excitability 
and network function in the brain. After being cloned in the 1990s, important progress has been made in understanding the 
mechanisms controlling the molecular and cellular properties of KARs, and the nature and extent of their regulation of wider 
neuronal activity. However, there have been significant recent advances towards understanding KAR trafficking through the 
secretory pathway, their precise synaptic positioning, and their roles in synaptic plasticity and disease. Here we provide an 
overview highlighting these new findings about the mechanisms controlling KARs and how KARs, in turn, regulate other 
proteins and pathways to influence synaptic function.
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Introduction
Glutamate is the major excitatory neurotransmitter in the 
CNS and participates in nearly all aspects of brain function. 
There are three major subclasses of ionotropic glutamate 
receptors, kainate receptors (KARs), AMPA receptors and 
NMDA receptors. KARs are widely distributed throughout 
the brain and, depending on the cell type in question, they 
can be localised at pre-, post- and/or extrasynaptic sites. In 
general, presynaptic KARs modulate both excitatory and 
inhibitory neurotransmitter release, postsynaptic KARs 
contribute to excitatory neurotransmission and extrasynap-
tic KARs play a role in determining neuronal excitability 
(for reviews of KAR physiology see [1–4]). For reasons 
that remain unclear, compared to AMPARs and NMDARs, 
synaptic KAR ionotropic responses are highly restricted 
to subsets of excitatory synapses. For example, some neu-
rons, including CA1 pyramidal neurons and dispersed hip-
pocampal cultures display robust KAR currents following 
kainate application [5, 6] but they lack synaptically-evoked 
ionotropic postsynaptic excitatory post-synaptic currents 
 KAR(EPSCs) [6–8]. Intriguingly, it has been proposed that 
 KAR(EPSCs) are present only at synapses that do not contain 
 AMPAR(EPSCs) [9, 10].
Remarkably, despite their classical ion channel structure, 
KARs can also signal via a non-canonical G-protein cou-
pled metabotropic cascade [11]. In contrast, postsynaptic 
metabotropic KAR signalling is much more widespread than 
ionotropic KAR signalling [12, 13] and recent discoveries 
have highlighted their previously unsuspected roles in neu-
romodulation. For example, they regulate inhibitory trans-
mission by controlling surface expression of the chloride 
transporter KCC2 [14] and mediate certain forms of synaptic 
plasticity [15, 16]. For extensive reviews of metabotropic 
KARs see [4, 17].
Our aim here is to provide an overview of recent advances 
in understanding the cellular regulation of KARs and their 
interacting proteins, and how these processes influence 
KAR-mediated synaptic transmission and plasticity. We 
highlight what is known, what remains to be established, 
and outline the future perspectives for KAR research and 
how it will impact on our understanding of brain function 
and dysfunction in disease.
 * Jeremy M. Henley 
 j.m.henley@bristol.ac.uk
 * Kevin A. Wilkinson 
 Kevin.Wilkinson@bristol.ac.uk
1 School of Biochemistry, Centre for Synaptic Plasticity, 
Biomedical Sciences Building, University of Bristol, 
Bristol BS8 1TD, UK
 Neurochemical Research
1 3
Nomenclature of KAR Subunits
Since their initial cloning [18, 19] the names of specific 
KAR subunits have changed to conform to a simpler, more 
systematic naming system. This can lead to considerable 
confusion in the field since many seminal early papers use 
the old nomenclature. Nonetheless, since 2009, the Interna-
tional Union of Basic and Clinical Pharmacology (IUPHAR) 
naming system has been almost universally adopted. Briefly, 
the subunits formerly most commonly referred to as GluR5, 
GluR6, GluR7, KA1 and KA2 are now named GluK1, 
GluK2, GluK3, GluK4 and GluK5, respectively, and the 
genes encoding these proteins are named GRIK1-5 [20].
KARs from Birth to Maturity
KAR Structure and Assembly
KARs are heteromeric assemblies containing four subu-
nits. Each subunit has a large extracellular N-terminal 
domain (NTD), helical transmembrane domains (TMD) 
including three membrane spanning domains (M1, M3 
and M4) and a membrane re-entrant domain (M2), and 
an intracellular C-terminal domain (CTD). The latter part 
of the NTD (the last ~ 150 amino acids, S1) together with 
the extracellular loops between M3 and M4 (S2) form the 
ligand-binding domain (LBD) [21]. Recently, detailed 
structural information has been gained by solving the 
crystal structure of kainate receptor subunits and this is 
reviewed in detail elsewhere [22–25].
Heteromeric Assembly
Following protein synthesis, the NTDs initiate receptor 
assembly in the endoplasmic reticulum (ER) by facilitat-
ing dimer formation, and the dimerization of two dimers 
then leads to the formation of tetrameric receptors. Based 
on affinity for their ligand, KAR subunits have been grouped 
into low affinity (GluK1-3) and high affinity (GluK4-5) 
receptors. Studies on recombinant systems have shown 
that low affinity GluK1-3 subunits can form ion channels 
as both homomers and heteromers but high affinity GluK4 
and GluK5 subunits can only form heteromeric functional 
ion channels when complexed with the low-affinity subunits 
[19, 26, 27]. The most abundant subunit combination in the 
brain comprises GluK2 and GluK5. This occurs, at least in 
part, because widely distributed contacts within the NTD of 
GluK2 and GluK5 favour the assembly of functional hetero-
meric receptors over homomeric receptors [28].
Alternative Splicing
Regions within the N- and C- terminal domains of KAR 
subunits can undergo alternative RNA splicing. For instance, 
the extracellular N-terminal domain of GluK1 can produce 
two variants,  GluK11 and  GluK12 [29], while the C-termi-
nus has four splice variants, GluK1a, GluK1b, GluK1c and 
GluK1d [30, 31]. Splice variants have also been reported at 
the C-termini of both GluK2 and GluK3; GluK2a/GluK2b/
GluK2c and GluK3a/GluK3b, respectively [32–34]. C-ter-
minal alternative splicing of KAR subunits has been shown 
to greatly affect the ability of receptors to exit the ER and 
accumulate at the cell surface. Furthermore, different C-ter-
mini facilitate distinct protein–protein interactions and it is 
likely they provide mechanisms for nuanced tuning of spe-
cific KARs at particular locations [35–37].
RNA Editing
In addition to splicing, further diversity arises from varying 
degrees of RNA editing in GluK1 and GluK2 subunits [38, 
39]. For example, Q/R editing in the pore-lining region of 
GluK2 results in a change from the genomically encoded 
glutamine residue to an arginine. This change alters the 
properties of the resultant KAR from calcium permeable to 
calcium impermeable and also alters the biophysical prop-
erties of the channel [40]. Furthermore, GluK2 Q/R editing 
reduces its ability to assemble with other subunits, leading to 
its accumulation as monomers and dimers that are retained 
in the ER [41].
It is well established that GluK1/GluK2 editing is devel-
opmentally controlled through regulation of the enzyme that 
also catalyses GluK1/2 RNA editing, ADAR2 [42–44]. For 
an excellent recent review see [45]. ADAR2 levels are low 
in embryonic brain and during development ADAR2 levels 
increase [46]. After birth ~ 80% of GluK2 and 40% GluK1 
are edited, which leads to fewer surface KARs and lower 
conductance and  Ca2+ permeability [47]. Furthermore, 
recent evidence has suggested that the ADAR2 dependent 
Q/R editing of GluK2 is also dynamically regulated during 
homeostatic scaling [48]. Suppression of synaptic activity 
with TTX results in upscaling of KAR surface expression, 
which is, at least in part, due to reduced Q/R editing of 
GluK2 [48]. Therefore, this developmental and homeostatic 
regulation of GluK2 Q/R editing likely control processes 
such as synaptogenesis [49, 50], plasticity [40] and pathol-
ogy [47].
KAR Trafficking Through the Secretory Pathway
The accurate and timely delivery of KARs to specific pre-, 
post- and extrasynaptic locations is fundamental to many 
aspects of neuronal function. Most research efforts have 
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focused on the processes of transcription, endocytosis, recy-
cling and degradation (for reviews see [4, 51]). However, 
after assembly, tetrameric KARs need to traffic through the 
secretory pathway to reach the cell surface and be appropri-
ately targeted. Until recently, it was unknown whether these 
early KAR trafficking steps occur locally in dendrites and, 
importantly, how these processes are regulated.
Local Dendritic Translation and Secretory Pathway 
Trafficking
In neurons, mRNAs can be trafficked to distant sites in axons 
and dendrites for local translation and processing [52–57]. 
A range of neuronal transmembrane proteins, including 
AMPARs, NMDARs and  GABABRs, can be translated using 
both somatic and dendritically localised ribosome patterned 
rough ER. They then traffic from the ER using dendritic ER 
exit sites and utilise the somatic Golgi or dendritic Golgi 
outposts for mature glycosylation [48, 58–62]. Importantly, 
all of the secretory pathway machinery appears to be pre-
sent in neurites as iGluRs can mature in isolated dendrites 
[63]. For example, AMPAR mRNAs traffic into dendrites, 
under the control of synaptic activity, to create local utiliz-
able pools of mRNA for local translation [64].
Recently, using the RUSH system, which allows the syn-
chronous release and visualization of cargo proteins traf-
ficking through the secretory pathway [65, 66], it has been 
demonstrated that GluK2-containing KARs utilise these 
local secretory pathway systems for their delivery to the cell 
surface [48] (Fig. 1). However, the functional consequences 
that result from KARs utilising these local secretory path-
way systems remain to be established.
Activity Dependent Secretory Pathway Trafficking
Although there is a strong base of knowledge about the 
activity-dependent regulation of KAR endocytosis and 
recycling [13, 15, 67–71], compared to AMPARs [72] 
and tsVSVG cargo [73], little is known about the activity-
dependence of secretory pathway trafficking of KARs. A 
very recent study reported that secretory pathway KAR traf-
ficking is indeed highly regulated in multiple different cellu-
lar activity contexts [48]. Activation of surface KARs results 
in a decrease in secretory pathway trafficking of de novo 
GluK2-containing KARs from the ER to the cell surface, 
demonstrating that KAR secretory pathway trafficking is 
subject to a negative feedback mechanism controlling KAR 
surface levels. Mechanistically, this pathway is dependent 
on the PDZ ligand of GluK2, since a mutant lacking this 
Fig. 1  Control of KAR trafficking through the secretory pathway. 
KAR trafficking is controlled at multiple levels under basal and activ-
ity-dependent conditions. PKC phosphorylation of the GluK2 subu-
nit at S846 and S868 reduces ER exit of GluK2-containing recep-
tors. Activation of surface KARs leads to a feedback mechanism that 
reduces forward trafficking of KARs from the ER, via a mechanism 
that requires the PDZ ligand of GluK2. Furthermore, induction of 
synaptic scaling via inhibiting neuronal activity with TTX leads to 
upscaling of KARs, at least in part via reduced RNA editing of the 
GluK2 subunit, favouring forward trafficking of GluK2-containing 
KARs. Finally, in addition to using somatic Golgi for post-ER pro-
cessing, KARs can also use local secretory pathway systems in den-
drites
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protein interaction site is insensitive to the effects of kainate 
on secretory pathway trafficking, however the GluK2 inter-
acting partner responsible remains to be determined [48].
Roles of GluK5 in Trafficking
As well as interactions with the GluK2 subunit, interactions 
with GluK5 also determine flux through the secretory path-
way. ER retention sequences in the C-terminus of GluK5 
facilitate its interaction with the COPI coat complex, driving 
retrograde Golgi to ER trafficking of KARs, and acting as an 
ER retrieval mechanism [74]. This interaction is disrupted 
by the heteromerization of GluK2 with GluK5 and bind-
ing to 14-3-3ζ, which promotes forward trafficking to the 
cell surface, both driving ER exit and favouring assembly 
of heteromeric KARs [74].
Post‑translational Modifications
Further tight control of the ER exit and secretory pathway 
trafficking of KARs is also provided by post-translational 
modifications, most notably PKC phosphorylation of GluK2 
at residues S846 and S868 [48, 75], which act to restrict 
forward trafficking of GluK2-containing KARs.
Thus, far from being a passive process, ER exit of KARs 
and flux through the secretory pathway is emerging as a 
major point of regulation in determining the surface expres-
sion of KARs under basal and activity-dependent conditions 
(summarised in Fig. 1).
Synaptic Positioning and Function of KARs
Given the highly-ordered targeting and localisation of KARs 
at distinct synaptic and sub-synaptic compartments, a key 
question in the field relates to how KARs are targeted to, 
and retained at, specific pre- or postsynaptic locations. While 
many of the factors that mediate this distribution are yet to 
be determined, as discussed below, recent data suggest that 
structural aspects of the receptor subunits, the presence of 
Neto auxiliary proteins in the KAR complex and the secreted 
C1q-like proteins play important roles in these processes 
(Fig. 2).
Postsynaptic KARs
Role of the GluK2 C‑Terminus in Synaptic Localisation
In the cerebellum, KARs are located post-synaptically on 
cerebellar granule cells, which receive inputs from mossy 
fibres. These receptors comprise GluK2/5 and the auxiliary 
subunit Neto2 [76] (see below). Synaptic localisation of this 
complex is dependent on the GluK2 subunit, since ablation 
of GluK5 or Neto2 has no effect on levels of GluK2/Neto2 
or GluK2/GluK5, respectively, in the postsynaptic density 
(PSD) fraction [76, 77]. Furthermore, knock-in mice in 
which the intracellular C-terminus of GluK2 is replaced with 
the C-terminus of the AMPAR subunit GluA1 do not exhibit 
synaptic KAR responses in cerebellar slices [77]. Notably, 
whole cell KAR currents were unaffected, demonstrating a 
specific role for the GluK2 C-terminus in synaptic incor-
poration of KARs at cerebellar synapses but not in recep-
tor surface expression [77]. Furthermore, these mice show 
reduced postsynaptic KAR responses at MF-CA3 synapses 
in the hippocampus, the prototypical KAR-containing syn-
apse in the brain, but no reduction in total KAR responses, 
again indicating a specific role for the GluK2 C-terminus in 
synaptic incorporation, but not surface expression, of KARs 
[77].
Roles of GluK4 and GluK5 in the Synaptic Specificity of KARs
While the C-terminus of GluK2 seems to be necessary 
for synaptic incorporation, synapse specificity in the hip-
pocampus has been shown to be dependent on the GluK4 
and GluK5 subunits. Postsynaptic KARs at MF-CA3 syn-
apses are lost in mice lacking both of these subunits [78]. 
Moreover, in GluK4/5−/− mice there is a redistribution of 
GluK2 immunolabelling to more distal dendrites in CA3 
pyramidal neurons [77], suggesting GluK4/5 are crucial 
determinants of the synapse specificity of KARs in the hip-
pocampus. Interestingly, viral re-expression of GluK5 in the 
Fig. 2  Mechanisms of KAR synaptic localisation. At mossy fibre-
CA3 (MF-CA3) synapses, presynaptically released C1ql proteins 
cluster KARs through binding to KAR subunit extracellular domains, 
and forming a tripartite trans-synaptic complex with presynaptic 
neurexin 3. KAR synaptic incorporation is also promoted through 
interactions between the GluK2 C-terminus and the trans-synaptic 
adhesion molecule N-cadherin, and through interactions between the 
C-termini of GluK1, GluK2 and GluK5 (and potentially Neto1) and 
PSD95
Neurochemical Research 
1 3
hippocampus of GluK4/5−/− mice rescued GluK2 signal in 
stratum lucidum, but this did not occur for a GluK5 chimera 
in which the extracellular N-terminus was replaced with that 
of GluK2 [77], which the authors attribute to the ability of 
the N-terminus of GluK5 to bind to the mossy fibre-enriched 
C1q-like proteins (see below).
Proteins that Interact with KARs to Define 
Postsynaptic Localisation
N‑Cadherin
The fact that MF-CA3 synapses in  GluK2−/− mice lack post-
synaptic KAR responses [79] has allowed examination of the 
factors required for their effective synaptic positioning by re-
expressing wild-type or mutant GluK2 in CA3 neurons. The 
last 20 amino acids of GluK2 are required for KAR incor-
poration at MF-CA3 synapses [80] and this region mediates 
interactions between GluK2 and the neuronal cell adhesion 
molecule N-cadherin [81]. At MF-CA3 synapses in wild-
type mice, expression of a dominant-negative N-cadherin 
reduced KAR EPSCs, as did knockdown of N-cadherin 
mediated by expression of Cre recombinase in CA3 cells 
from N-cadherin floxed mice [80]. Together, these findings 
demonstrate GluK2 binding to N-cadherin is a key determi-
nant of GluK2 recruitment to MF-CA3 synapses.
PSD95
The synaptic scaffold protein PSD95 binds to the C-terminal 
PDZ ligands of the core KAR subunits GluK1, GluK2 and 
GluK5 [82, 83]. PSD95 also binds to the auxiliary subu-
nit Neto1 [84], and accelerates the recovery of GluK2 from 
desensitisation [85]. The KAR component of the EPSC at 
MF-CA3 synapses is reduced in PSD95 knockout mice, sug-
gesting a role for this interaction in KAR synaptic localisa-
tion [86]. However, whether this is due to direct binding of 
KARs to PSD95 and, if it is, which subunits are responsible, 
remains to be determined. Moreover, as discussed below, 
regulation of the interaction between GluK5 and PSD95 
is required for long-term depression (LTD) of KARs at 
MF-CA3 synapses [87].
C1ql
The C1q-like proteins are a family of secreted synaptic 
organisers [88]. Two members of this family, C1ql2 and 
C1ql3, are highly expressed by hippocampal mossy fibres 
and contribute to the localisation of KARs to mossy fibre 
synapses in CA3 neurons [77, 89]. In heterologous cells, 
C1ql2 and 3 bind to the N-terminal domains of GluK2 and 
GluK4 [89], although another study instead observed bind-
ing to GluK5 [77]. C1ql2 and 3 are present at MF-CA3 
synapses, and their levels are reduced in slices from 
 GluK2−/− or  GluK4−/− mice, suggesting GluK2 and GluK4 
act as binding sites for C1ql2/3 [89]. Moreover, GluK2/3 
immunoreactivity is markedly decreased in CA3 stratum 
lucidum in C1ql2/3 knockout mice, and KAR EPSCs at 
MF-CA3 synapses are reduced to levels similar to those 
observed in  GluK2−/− mice. The presynaptic adhesion 
molecule neurexin 3 binds to secreted C1ql2/3 and a neu-
rexin 3-C1ql-KAR complex was isolated in co-cultures 
of HEK293 cells expressing neurexin 3 and C1ql2/3 and 
neurons [89]. Thus, specific secretion of C1ql proteins at 
mossy fibres provides the basis for a trans-synaptic complex 
that clusters KARs postsynaptically at MF-CA3 synapses 
(Fig. 2).
Neto1 and Neto2
Neto1 and Neto2 are single pass transmembrane proteins 
that associate with KAR complexes through binding to the 
GluK1-3 subunits [90, 91]. Neto1 is expressed abundantly in 
the hippocampus and is a component of postsynaptic KARs 
at MF-CA3 synapses [91] whereas Neto2 is more highly 
expressed in the cerebellum [90]. The effects of Neto pro-
teins on KAR channel properties have been studied exten-
sively (reviewed in [92–95]), but, briefly, Neto proteins 
generally slow the deactivation kinetics of KARs, which 
accounts for their different properties in vivo compared to 
exogenously expressed KARs in cell lines that do not con-
tain Netos. Furthermore, it has also recently been shown that 
Neto proteins control the function of both somatodendritic 
and presynaptic KARs in somatostatin, cholecystokinin/can-
nabinoid receptor 1, and parvalbumin-containing interneu-
rons to regulate neuronal network inhibition [96]. However, 
as outlined below, how Neto proteins affect the trafficking 
and synaptic incorporation of KARs is less well established 
with the current literature containing apparently contradic-
tory results.
Netos and GluK2
Initial studies observed no effect of Neto1 or Neto2 in 
mediating surface expression of GluK2 in heterologous 
systems [90, 91] nor any effects on the abundance of GluK2 
or GluK5 in PSD fractions from Neto1 knockout mice 
[91]. Furthermore, co-expression of Neto1 or Neto2 did 
not enhance exogenous KAR responses in CA1 pyramidal 
neurons, which normally lack postsynaptic KAR EPSCs, 
arguing against a role for Netos in synaptic incorporation 
of GluK2-containing KARs [9]. Other studies, however, 
reported a reduction in synaptic GluK2 in the hippocam-
pus of Neto1 knockout mice [97, 98], and from cerebellar 
PSD fractions from Neto2 knockout mice [99], supporting 
a role for Neto proteins in the synaptic targeting of GluK2. 
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Moreover, recent studies have reported that Neto1 and Neto2 
enhance GluK2 surface expression in HEK293 cells [100] 
and that injection of Neto2 with GluK2 into oocytes potenti-
ates GluK2 surface expression [77]. Given these apparently 
contradictory results, the precise roles of Neto proteins in the 
trafficking and targeting of GluK2-containing KARs remains 
to be defined.
Netos and GluK1
Neto proteins have also been reported to be involved in the 
trafficking of GluK1-containing KARs. Transfection of 
Neto2 with GluK1 promotes GluK1 surface expression in 
both COS-7 cells and cultured hippocampal neurons, and 
drives the synaptic incorporation of GluK1-containing 
KARs [101]. Consistent with this role, co-transfection of 
either Neto1 or Neto2 with GluK1 in CA1 pyramidal cells in 
hippocampal slice cultures enhances GluK1 surface expres-
sion and synaptic targeting [9, 102]. It should be noted, how-
ever, that since these studies rely on overexpression of KAR 
subunits in cells that do not usually express GluK1 [6, 103] 
or exhibit synaptic KAR responses [6–8], the relevance of 
Neto proteins to GluK1 trafficking in vivo requires further 
examination.
Overall, although there is not yet a clear consensus, 
accumulating evidence suggests Neto proteins do influ-
ence surface expression and synaptic targeting of KARs 
under some circumstances. The apparently conflicting data 
regarding the roles of Netos in KAR trafficking and synap-
tic positioning can, at least in part, be attributed to the use 
of different model systems, clonal cell lines and neuronal 
subtypes, and experimental conditions. Thus, the current 
inconsistencies may reflect a complex relationship between 
Netos and KARs, which can be affected differential subunit 
expression and the availability of cell type-specific interact-
ing proteins. Moreover, GluK2 is subject to multiple, coor-
dinated post-translational modifications (PTMs) including 
phosphorylation [75], SUMOylation [67, 69], ubiquitina-
tion [104, 105] and palmitoylation [71, 106], each of which 
could potentially directly or indirectly influence the actions 
of Netos. Clearly, further work is required to will determine 
the molecular mechanisms, under what circumstances, and 
for which subunit combinations Netos regulate KAR traf-
ficking and targeting in vivo.
KAR Post‑translational Modifications 
and Post‑synaptic Localisation
CaMKII Phosphorylation of GluK5
LTD of KARs at MF-CA3 synapses is induced by a spike 
timing-,  Ca2+ influx-, and CaMKII-dependent plasticity 
mechanism, which is absent in slices from  GluK5−/− mice 
[87]. CaMKII phosphorylates the C-terminal domain of 
GluK5 in vitro and a phosphomimetic mutation enhances 
surface expression, but reduces synaptic localisation, in 
neurons. GluK5 phosphorylation enhances lateral mobil-
ity and reduces the interaction between GluK5 and PSD95. 
Moreover, while re-expression of GluK5 in  GluK5−/− slices 
restored KAR-LTD, expression of a non-phosphorylatable 
GluK5 did not, demonstrating that direct phosphorylation 
of GluK5 by CaMKII is required for this form of KAR LTD 
[87]. Thus, these data indicate that CaMKII phosphorylation 
of GluK5-containing KARs regulates their synaptic locali-
sation by antagonising the interaction between GluK5 and 
PSD95 (Fig. 3).
Fig. 3  Mechanisms of 
KAR-LTD. a At MF-CA3 
synapses, LTD induction 
leads to CaMKII-mediated 
phosphorylation of the GluK5 
subunit, reducing its ability 
to bind PSD95. This reduced 
anchoring of GluK5-containing 
KARs promotes their lateral 
mobility and diffusion away 
from the postsynapse, resulting 
in LTD of KAR EPSCs. b An 
alternative LTD mechanism 
results in PKC-dependent 
phosphorylation (not shown) 
and subsequent SUMOylation 
of the GluK2 subunit. This 
then leads to endocytosis of 
GluK2-containing KARs and 
LTD of KAR-mediated synaptic 
transmission
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PKC Phosphorylation of GluK2
PKC phosphorylation of GluK2 at S846 and S868 regulates 
the surface expression of GluK2-containing KARs at several 
levels. It affects both GluK2 transit through the secretory 
pathway [48, 75] and KAR endocytosis and recycling back 
to the plasma membrane [15, 75]. Phosphorylation of S846 
promotes basal internalisation of GluK2-containing KARs in 
both HeLa cells and neurons [75], potentially via regulating 
the interaction between GluK2 and 4.1 proteins [71]. Fur-
thermore, phosphorylation of both sites occurs in response 
to kainate stimulation of cultured neurons, and phosphoryla-
tion at S868 is required for agonist-induced endocytosis of 
GluK2, by promoting SUMOylation at lysine 886 [15, 69, 
107] (see below). It should be noted, however, that PKC 
phosphorylation of S868 also appears to be involved in recy-
cling of endocytosed GluK2 back to the plasma membrane 
[15], suggesting that whether phosphorylation of S868 pro-
motes insertion or removal of GluK2 from the plasma mem-
brane is likely to be context-dependent.
SUMOylation
SUMOylation is a post-translational modification that results 
from the conjugation of a member of the ~ 11kD SUMO 
family to lysine residues in substrate proteins [108]. GluK2 
is SUMOylated at a single lysine residue in its intracellu-
lar C-terminus, K886, resulting in agonist-induced inter-
nalisation of GluK2-containing KARs [67]. Infusion of the 
catalytic domain of the deSUMOylating enzyme SENP1 
increases KAR currents at MF-CA3 synapses, highlighting 
SUMOylaton as an endogenous regulator of the number of 
synaptic KARs [67]. Subsequent studies have demonstrated 
that SUMOylation of GluK2 is enhanced by prior PKC-
mediated phosphorylation of serine 868 and is required for 
LTD of kainate receptors at MF-CA3 synapses [15, 69].
Ubiquitination
One major functions of protein ubiquitination is to target 
proteins for lysosomal or proteasomal degradation [109]. 
A recent study identified that the Parkinson’s disease-
associated ubiquitin ligase Parkin directly interacts with 
and ubiquitinates the C-terminus of GluK2 [105]. Parkin 
ubiquitinates GluK2 in both heterologous cells and cultured 
neurons, and knockdown of Parkin increased GluK2 sur-
face expression and increased vulnerability of hippocampal 
neurons to kainate-induced excitotoxicity. Furthermore, in 
a mouse model of autosomal recessive juvenile Parkinson’s 
expressing a truncated form of Parkin, there are increased 
levels of GluK2 in substantia nigra and corresponding 
increases in cortex samples from human patients express-
ing mutations in Parkin [105]. Thus, GluK2 is a Parkin target 
that may contribute to the excitotoxic cell death of substantia 
nigra neurons in Parkinson’s disease.
KARs in Plasticity
KARs are involved in both excitatory and inhibitory neuro-
transmission, controlling both short and longer-term plas-
ticity. These properties have been extensively reviewed [2, 
11] and we confine our discussion largely to the most recent 
findings relating to the role of postsynaptic KARs as induc-
ers of long-term plasticity.
KAR Regulation of Excitatory Neurotransmission
Presynaptic KARs decrease glutamate release at CA3-CA1 
pyramidal cell synapses [110–112]. Intriguingly, however, 
KARs have also been shown to facilitate glutamate release 
upon application of nanomolar concentrations of kainate. 
This facilitation of glutamate release requires KAR activa-
tion resulting in the accumulation of presynaptic calcium, 
the production of  Ca2+–calmodulin complexes and the 
activation adenylate cyclase and PKA [113–115]. Thus, at 
certain synapses, KARs can exert bidirectional modulatory 
actions on glutamate release related to the extent of their 
activation (for recent review see [3]).
Postsynaptic KARs at MF-CA3 synapses undergo plas-
tic changes, and exhibit several forms of LTD that can 
be induced by different stimulation protocols [15, 87]. 
Chamberlain et al. showed that SUMOylation of GluK2 
is required for activity-dependent long-term depression 
of kainate receptor-mediated synaptic transmission (KAR 
LTD). They We further demonstrated that a critical trig-
ger for SUMOylation is GluK2 phosphorylation by protein 
kinase C (PKC) and that this sequence of events is required 
for KAR LTD and that SUMOylation can act as the switch 
between enhanced or decreased surface expression of KARs 
after PKC phosphorylation [15].
Furthermore, in cultured neurons, activity-dependent 
up- or down-regulation of surface KARs can be induced by 
differential agonist application protocols [13, 68]. KAR sur-
face expression is also subject to homeostatic plasticity and 
can be ‘scaled’ by manipulating neuronal excitability [48]. 
Intriguingly, beyond being regulated by plasticity them-
selves, there is a growing appreciation that KARs also func-
tion as postsynaptic inducers of synaptic plasticity (Fig. 3).
Recently, a novel form of AMPAR-LTP was discovered 
at CA3-CA1 synapses that is mediated by activation of 
postsynaptic KARs (KAR-LTPAMPAR [16]). Despite the fact 
that CA1 pyramidal cells exhibit essentially no postsynaptic 
KAR EPSCs [6, 8, 9, 102, 116], activation of postsynaptic 
KARs by high-frequency stimulation of Schaffer collaterals 
inhibits a slow after-hyperpolarization current that regulates 
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excitability in hippocampus (IsAHP) through a metabotropic 
cascade [117, 118], suggesting receptors are postsynaptically 
localised. Remarkably, however, at these synapses, KARs, 
which have a classical ion channel structure, signal primar-
ily through a G protein-dependent pathway (for review see 
[17]).
Consistent with this, stimulation protocols that acti-
vate postsynaptic KARs on CA1 neurons induce LTP 
of AMPARs via a metabotropic signalling pathway [16]. 
 GluK2−/− mice lack this novel form of plasticity, indicat-
ing an absolute requirement for this subunit in induction of 
KAR-LTPAMPAR (Fig. 4). Similar to inhibition of IsAHP, 
KAR-LTPAMPAR is mediated by activation of pertussis 
toxin-sensitive G-proteins, and requires activation of PKC 
and PLC. Furthermore, similar to LTP induced by activation 
of NMDARs, KAR-LTPAMPAR is mediated by an increase 
in surface AMPARs supplied by recruitment of recycling 
endosomes to spines and also leads to structural plasticity, as 
determined by an increase in spine size and maturation [16].
Thus, although the exact mechanisms are still to be deter-
mined, it is clear that KAR metabotropic signalling plays 
a key role in directly mediating certain forms of AMPAR-
mediated plasticity at CA1 synapses.
KAR Regulation of Inhibitory Neurotransmission
KAR Regulation of GABA Release
An important facet of KAR physiology is that they coordi-
nate and regulate neuronal and network activity via regula-
tion of both excitatory and inhibitory transmission. Presyn-
aptic KARs downregulate GABA release from interneurons 
in the hippocampus through a metabotropic PKC and PLC 
dependent pathway that reduces inhibitory postsynaptic cur-
rents (IPSCs) [119].
KARs and  GABAARs
Moreover, postsynaptic KAR metabotropic signalling 
depresses synaptic  GABAARs while at the same time poten-
tiating extrasynaptic  GABAARs, in a process that decreases 
synaptic inhibitory drive to facilitate synaptic plasticity, 
while simultaneously protecting against neuronal over-exci-
tation by promoting extrasynaptic inhibition [120].
KARs and KCC2
In addition to this direct effect on  GABAAR-mediated trans-
mission, KARs separately regulate the potassium-chloride 
cotransporter KCC2. KCC2 is crucial because it establishes 
the electrochemical chloride gradient for postsynaptic inhi-
bition through  GABAARs [121, 122] and its dysregulation 
is implicated in autism spectrum disorder (ASD; [123]) 
and epilepsy [124]. KCC2 interacts with both Neto2 [125] 
and GluK2 [126], which increase the total abundance and 
enhance surface expression of KCC2 [14]. KCC2 and GluK2 
form macromolecular assemblies that traffic together, and 
this complex regulates intraneuronal chloride homeostasis 
to support  GABAAR-mediated transmission [126]. In addi-
tion, this process is further controlled by phosphorylation of 
serines 846 and 868 in GluK2 to determine surface KCC2 
levels [14]. These findings establish clear roles for KARs as 
modulators of postsynaptic inhibitory transmission.
KARs in Disease
Dysregulation of common molecular pathways underlies 
multiple neurological and neurodegenerative diseases and 
there is mounting evidence that KAR dysfunction could be 
one such feature (reviewed in [127, 128]).
Epilepsy
KAR dysfunction is particularly closely associated with 
temporal lobe epilepsy (TLE) [129], and  GluK2−/− mice 
exhibit significantly fewer seizures than wild-type counter-
parts [79]. TLE is associated with abnormal sprouting of 
recurrent mossy fibres, which synapse onto dentate gyrus 
cells [130–132] and this abnormal sprouting is also reduced 
in  GluK2−/− mice [133]. Consistent with the requirement 
for recruitment of KARs to postsynaptic sites for seizure 
activity, despite induction of MF sprouting in an animal 
model of TLE, C1ql2/3 double KO mice are resistant to sei-
zures [89] and genetic silencing of KARs at CA3 synapses 
attenuates kainate-induced seizures [134]. Together, these 
Fig. 4  Mechanism of KAR-LTPAMPAR. At CA3-CA1 synapses, acti-
vation of postsynaptic KARs leads to LTP of AMPAR-mediated syn-
aptic transmission. This occurs through KAR-mediated activation of 
a pertussis toxin-sensitive G protein, activation of phospholipase C 
(PLC), PKC, and increased exocytosis of AMPARs from recycling 
endosomes
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studies suggest that recurrent synaptic activity, mediated 
by postsynaptic KARs, drives seizure activity in TLE, and 
highlights KARs as an attractive therapeutic target in the 
treatment of this disorder.
KARs and Other Neurological Disorders
In addition to TLE, both gain [135] and loss [136, 137] of 
GluK2 have been reported to lead to ASD-like phenotypes. 
Furthermore, duplication of the GluK4 gene has been associ-
ated with autism [138] and, consistent with this, overexpres-
sion of GluK4 in the forebrain of mice causes severe anxiety 
and ASD-like behaviours [139]. Additionally, GluK4 has 
been linked with treatment-resistant depression [140], and 
disruption of the gene encoding GluK4 has been observed 
in a patient with schizophrenia and mental retardation [141].
Most recently it has been reported that complete ablation 
of all KAR subunits results in disrupted corticostriatal func-
tion and dramatic obsessive-compulsive-like behaviour with 
severe self-grooming [142]. Together with the previous stud-
ies, these new observations support the notion that KAR-
mediated control of network activity is a key determinant of 
higher brain function, and that disruption of these pathways 
can lead to multiple neurological disorders.
Perspectives
Although historically much less studied than AMPARs 
or NMDARs, there is a currently a renaissance in KAR 
research fuelled by the realisation that they are multifunc-
tional neuronal modulators that have roles in health and dis-
ease far beyond those previously appreciated.
To understand how KARs exert these regulatory effects, it 
is necessary to define how KARs themselves are controlled 
and how they interact with, and regulate, other proteins and 
systems. Furthermore, while there is a growing apprecia-
tion of the multifaceted roles played by KARs, a number 
of fundamental questions remain unanswered. For example, 
while it is widely-accepted that KARs can signal both iono-
tropically and metabotropically through G-proteins, how this 
dual signaling occurs, and what determines which ‘mode’ 
of signaling an individual KAR complex utilizes remains 
almost entirely unexplored. In addition, while we are begin-
ning to understand the molecular events that control the spe-
cific distribution and synaptic localization of KARs, how 
these mechanisms cooperate to orchestrate the highly selec-
tive distribution of KARs in the brain remains an important 
unanswered question. Finally, although KARs can induce 
plasticity of AMPARs, exactly how this occurs, how wide-
spread this form of plasticity is in the brain, and whether 
postsynaptic KARs can direct other forms of bidirectional 
synaptic plasticity remain unknown.
We expect that further studies examining how KAR local-
isation and signalling at pre- and postsynaptic sites impacts 
on neuronal function will answer many of these remaining 
questions, and will transform our understanding of the roles 
KARs play in development, plasticity and disease.
Open Access This article is distributed under the terms of the Creative 
Commons Attribution 4.0 International License (http://creativecom-
mons.org/licenses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
 1. Sihra TS, Flores G, Rodriguez-Moreno A (2014) Kainate 
receptors: multiple roles in neuronal plasticity. Neuroscientist 
20:29–43
 2. Carta M, Fievre S, Gorlewicz A, Mulle C (2014) Kainate recep-
tors in the hippocampus. Eur J Neurosci 39:1835–1844
 3. Sihra TS, Rodriguez-Moreno A (2013) Presynaptic kainate 
receptor-mediated bidirectional modulatory actions: mecha-
nisms. Neurochem Int 62:982–987
 4. Lerma J, Marques JM (2013) Kainate receptors in health and 
disease. Neuron 80:292–311
 5. Ruano D, Lambolez B, Rossier J, Paternain AV, Lerma J (1995) 
Kainate receptor subunits expressed in single cultured hippocam-
pal neurons: molecular and functional variants by RNA editing. 
Neuron 14:1009–1017
 6. Bureau I, Bischoff S, Heinemann SF, Mulle C (1999) Kainate 
receptor-mediated responses in the CA1 field of wild-type and 
GluR6-deficient mice. J Neurosci 19:653–663
 7. Castillo PE, Malenka RC, Nicoll RA (1997) Kainate receptors 
mediate a slow postsynaptic current in hippocampal CA3 neu-
rons. Nature 388:182–186
 8. Granger AJ, Shi Y, Lu W, Cerpas M, Nicoll RA (2013) LTP 
requires a reserve pool of glutamate receptors independent of 
subunit type. Nature 493:495–500
 9. Sheng N, Shi YS, Lomash RM, Roche KW, Nicoll RA (2015) 
Neto auxiliary proteins control both the trafficking and biophysi-
cal properties of the kainate receptor GluK1. eLife 4:e11682
 10. Sheng N, Shi YS, Nicoll RA (2017) Amino-terminal domains 
of kainate receptors determine the differential dependence on 
Neto auxiliary subunits for trafficking. Proc Natl Acad Sci USA 
114:1159–1164
 11. Lerma J (2003) Roles and rules of kainate receptors in synaptic 
transmission. Nat Rev Neurosci 4:481–495
 12. Lourenco J, Matias I, Marsicano G, Mulle C (2011) Pharmaco-
logical activation of kainate receptors drives endocannabinoid 
mobilization. J Neurosci 31:3243–3248
 13. Gonzalez-Gonzalez IM, Henley JM (2013) Postsynaptic kain-
ate receptor recycling and surface expression are regulated by 
metabotropic autoreceptor signalling. Traffic 14:810–822
 14. Pressey JC, Mahadevan V, Khademullah CS, Dargaei Z, Chevrier 
J, Ye W, Huang M, Chauhan AK, Meas SJ, Uvarov P, Airaksinen 
MS, Woodin MA (2017) A kainate receptor subunit promotes the 
recycling of the neuron-specific  K+-Cl- co-transporter KCC2 in 
hippocampal neurons. J Biol Chem 292:6190–6201
 15. Chamberlain SE, Gonzalez-Gonzalez IM, Wilkinson KA, 
Konopacki FA, Kantamneni S, Henley JM, Mellor JR (2012) 
SUMOylation and phosphorylation of GluK2 regulate 
 Neurochemical Research
1 3
kainate receptor trafficking and synaptic plasticity. Nat Neurosci 
15:845–852
 16. Petrovic MM, Viana da Silva S, Clement JP, Vyklicky L, Mulle 
C, Gonzalez-Gonzalez IM, Henley JM (2017) Metabotropic 
action of postsynaptic kainate receptors triggers hippocampal 
long-term potentiation. Nat Neurosci 20:529–539
 17. Valbuena S, Lerma J (2016) Non-canonical signaling, the hidden 
life of ligand-gated ion channels. Neuron 92:316–329
 18. Bettler B, Boulter J, Hermans-Borgmeyer I, O’Shea-Greenfield 
A, Deneris ES, Moll C, Borgmeyer U, Hollmann M, Heine-
mann S (1990) Cloning of a novel glutamate receptor subunit, 
GluR5: expression in the nervous system during development. 
Neuron 5:583–595
 19. Egebjerg J, Bettler B, Hermans-Borgmeyer I, Heinemann S 
(1991) Cloning of a cDNA for a glutamate receptor subunit 
activated by kainate but not AMPA. Nature 351:745–748
 20. Collingridge GL, Olsen RW, Peters J, Spedding M (2009) A 
nomenclature for ligand-gated ion channels. Neuropharmacol-
ogy 56:2–5
 21. Hughes TE (1994) Transmembrane topology of the glutamate 
receptors. A tale of novel twists and turns. J Mol Neurosci 
5:211–217
 22. Karakas E, Regan MC, Furukawa H (2015) Emerging structural 
insights into the function of ionotropic glutamate receptors. 
Trends Biochem Sci 40:328–337
 23. Mollerud S, Frydenvang K, Pickering DS, Kastrup JS (2017) 
Lessons from crystal structures of kainate receptors. Neurop-
harmacology 112:16–28
 24. Zhu S, Gouaux E (2017) Structure and symmetry inform gating 
principles of ionotropic glutamate receptors. Neuropharmacol-
ogy 112:11–15
 25. Meyerson JR, Chittori S, Merk A, Rao P, Han TH, Serpe 
M, Mayer ML, Subramaniam S (2016) Structural basis of 
kainate subtype glutamate receptor desensitization. Nature 
537:567–571
 26. Werner P, Voigt M, Keinanen K, Wisden W, Seeburg PH 
(1991) Cloning of a putative high-affinity kainate receptor 
expressed predominantly in hippocampal CA3 cells. Nature 
351:742–744
 27. Herb A, Burnashev N, Werner P, Sakmann B, Wisden W, See-
burg PH (1992) The KA-2 subunit of excitatory amino acid 
receptors shows widespread expression in brain and forms ion 
channels with distantly related subunits. Neuron 8:775–785
 28. Kumar J, Schuck P, Mayer ML (2011) Structure and assem-
bly mechanism for heteromeric kainate receptors. Neuron 
71:319–331
 29. Bettler B, Boulter J, Hermansborgmeyer I, Osheagreenfield A, 
Deneris ES, Moll C, Borgmeyer U, Hollmann M, Heinemann S 
(1990) Cloning of a novel glutamate receptor subunit, GluR5—
expression in the nervous system during development. Neuron 
5:583–595
 30. Sommer B, Burnashev N, Verdoorn TA, Keinanen K, Sakmann 
B, Seeburg PH (1992) A glutamate receptor channel with high 
affinity for domoate and kainate. EMBO J 11:1651–1656
 31. Pinheiro P, Mulle C (2006) Kainate receptors. Cell Tissue Res 
326:457–482
 32. Schiffer HH, Swanson GT, Heinemann SF (1997) Rat GluR7 and 
a corboxy terminal splice variant, GluR7b, are functional kainate 
receptor subunits with a low sensitivity to glutamate. Neuron 
19:1141–1146
 33. Jaskolski F, Coussen F, Nagarajan N, Normand E, Rosenmund 
C, Mulle C (2004) Subunit composition and alternative splic-
ing regulate membrane delivery of kainate receptors. J Neurosci 
24:2506–2515
 34. Pahl S, Tapken D, Haering SC, Hollmann M (2014) Trafficking 
of kainate receptors. Membranes 4:565–595
 35. Ren Z, Riley NJ, Needleman LA, Sanders JM, Swanson GT, Mar-
shall J (2003) Cell surface expression of GluR5 kainate receptors 
is regulated by an endoplasmic reticulum retention signal. J Biol 
Chem 278:52700–52709
 36. Coussen F, Perrais D, Jaskolski F, Sachidhanandam S, Normand 
E, Bockaert J, Marin P, Mulle C (2005) Co-assembly of two 
GluR6 kainate receptor splice variants within a functional protein 
complex. Neuron 47:555–566
 37. Jaskolski F, Normand E, Mulle C, Coussen F (2005) Differential 
trafficking of GluR7 kainate receptor subunit splice variants. J 
Biol Chem 280:22968–22976
 38. Egebjerg J, Kukekov V, Heinemann SF (1994) Intron sequence 
directs RNA editing of the glutamate receptor subunit GluR2 
coding sequence. Proc Natl Acad Sci USA 91:10270–10274
 39. Howe JR (1996) Homomeric and heteromeric ion channels 
formed from the kainate type subunits GluR6 and KA2 have 
very small, but different unitary conductances. J Neurophysiol 
76:510–519
 40. Vissel B, Royle GA, Christie BR, Schiffer HH, Ghetti A, Tritto 
T, Perez-Otano I, Radcliffe RA, Seamans J, Sejnowski T, Wehner 
JM, Collins AC, O’Gorman S, Heinemann SF (2001) The role 
of RNA editing of kainate receptors in synaptic plasticity and 
seizures. Neuron 29:217–227
 41. Ball SM, Atlason PT, Shittu-Balogun OO, Molnar E (2010) 
Assembly and intracellular distribution of kainate receptors is 
determined by RNA editing and subunit composition. J Neuro-
chem 114:1805–1818
 42. Bernard A, Khrestchatisky M (1994) Assessing the extent of 
RNA editing in the TMII regions of Glur5 and Glur6 kain-
ate receptors during rat brain development. J Neurochem 
62:2057–2060
 43. Schmitt J, Dux E, Gissel C, Paschen W (1996) Regional analysis 
of developmental changes in the extent of GluR6 mRNA editing 
in rat brain. Brain Res Dev Brain Res 91:153–157
 44. Bernard A, Ferhat L, Dessi F, Charton G, Represa A, Ben-Ari 
Y, Khrestchatisky M (1999) Q/R editing of the rat GluR5 and 
GluR6 kainate receptors in vivo and in vitro: evidence for inde-
pendent developmental, pathological and cellular regulation. Eur 
J Neurosci 11:604–616
 45. Nishikura K (2016) A-to-I editing of coding and non-coding 
RNAs by ADARs. Nat Rev Mol Cell Biol 17:83–96
 46. Behm M, Wahlstedt H, Widmark A, Eriksson M, Ohman M 
(2017) Accumulation of nuclear ADAR2 regulates adenosine-
to-inosine RNA editing during neuronal development. J Cell Sci 
130:745–753
 47. Filippini A, Bonini D, La Via L, Barbon A (2016) The good and 
the bad of glutamate receptor RNA editing. Mol Neurobiol
 48. Evans AJ, Gurung S, Wilkinson KA, Stephens DJ, Henley JM 
(2017) Assembly, secretory pathway trafficking, and surface 
delivery of kainate receptors is regulated by neuronal activity. 
Cell Rep 19:2613–2626
 49. Tashiro A, Dunaevsky A, Blazeski R, Mason CA, Yuste R (2003) 
Bidirectional regulation of hippocampal mossy fiber filopodial 
motility by kainate receptors. A two-step model of synaptogen-
esis. Neuron 38:773–784
 50. Sakha P, Vesikansa A, Orav E, Heikkinen J, Kukko-Lukjanov 
TK, Shintyapina A, Franssila S, Jokinen V, Huttunen HJ, Lauri 
SE (2016) Axonal kainate receptors modulate the strength of 
efferent connectivity by regulating presynaptic differentiation. 
Front Cell Neurosci. https://doi.org/10.3389/fncel.2016.00003
 51. Contractor A, Mulle C, Swanson GT (2011) Kainate receptors 
coming of age: milestones of two decades of research. Trends 
Neurosci 34:154–163
 52. Bramham CR, Wells DG (2007) Dendritic mRNA: transport, 
translation and function. Nat Rev Neurosci 8:776–789
Neurochemical Research 
1 3
 53. Doyle M, Kiebler MA (2011) Mechanisms of dendritic mRNA 
transport and its role in synaptic tagging. EMBO J 30:3540–3552
 54. Holt CE, Schuman EM (2013) The central dogma decentralized: 
new perspectives on RNA function and local translation in neu-
rons. Neuron 80:648–657
 55. Ho VM, Dallalzadeh LO, Karathanasis N, Keles MF, Vangala S, 
Grogan T, Poirazi P, Martin KC (2014) GluA2 mRNA distribu-
tion and regulation by miR-124 in hippocampal neurons. Mol 
Cell Neurosci 61:1–12
 56. Buxbaum AR, Yoon YJ, Singer RH, Park HY (2015) Single-
molecule insights into mRNA dynamics in neurons. Trends Cell 
Biol 25:468–475
 57. Rangaraju V, Tom Dieck S, Schuman EM (2017) Local transla-
tion in neuronal compartments: how local is local? EMBO Rep 
18:693–711
 58. Horton AC, Ehlers MD (2004) Secretory trafficking in neuronal 
dendrites. Nat Cell Biol 6:585–591
 59. Cui-Wang T, Hanus C, Cui T, Helton T, Bourne J, Watson D, 
Harris KM, Ehlers MD (2012) Local zones of endoplasmic 
reticulum complexity confine cargo in neuronal dendrites. Cell 
148:309–321
 60. Quassollo G, Wojnacki J, Salas DA, Gastaldi L, Marzolo MP, 
Conde C, Bisbal M, Couve A, Caceres A (2015) A RhoA sign-
aling pathway regulates dendritic golgi outpost formation. Curr 
Biol 25:971–982
 61. Valenzuela JI, Perez F (2015) Diversifying the secretory routes 
in neurons. Front Neurosci 9:358
 62. Hanus C, Geptin H, Tushev G, Garg S, Alvarez-Castelao B, 
Sambandan S, Kochen L, Hafner AS, Langer JD, Schuman EM 
(2016) Unconventional secretory processing diversifies neuronal 
ion channel properties. eLife 5, e20609
 63. Kacharmina JE, Job C, Crino P, Eberwine J (2000) Stimulation 
of glutamate receptor protein synthesis and membrane insertion 
within isolated neuronal dendrites. Proc Natl Acad Sci USA 
97:11545–11550
 64. Grooms SY, Noh KM, Regis R, Bassell GJ, Bryan MK, Carroll 
RC, Zukin RS (2006) Activity bidirectionally regulates AMPA 
receptor mRNA abundance in dendrites of hippocampal neurons. 
J Neurosci 26:8339–8351
 65. Boncompain G, Perez F (2012) Synchronizing protein trans-
port in the secretory pathway. Curr Protoc Cell Biol. https://doi.
org/10.1002/0471143030.cb1519s57
 66. Boncompain G, Perez F (2014) Synchronization of secretory 
cargos trafficking in populations of cells. Methods Mol Biol 
1174:211–223
 67. Martin S, Nishimune A, Mellor JR, Henley JM (2007) SUMOyla-
tion regulates kainate-receptor-mediated synaptic transmission. 
Nature 447:321–325
 68. Martin S, Bouschet T, Jenkins EL, Nishimune A, Hen-
ley JM (2008) Bidirectional regulation of kainate receptor 
surface expression in hippocampal neurons. J Biol Chem 
283:36435–36440
 69. Konopacki FA, Jaafari N, Rocca DL, Wilkinson KA, Cham-
berlain S, Rubin P, Kantamneni S, Mellor JR, Henley JM 
(2011) Agonist-induced PKC phosphorylation regulates GluK2 
SUMOylation and kainate receptor endocytosis. Proc Natl Acad 
Sci USA 108:19772–19777
 70. González-González IM, Konopaki F, Rocca DL, Doherty AJ, 
Jaafari N, Wilkinson KA, Henley JM (2012) Kainate receptor 
trafficking. WIRES Membr Transp Signal 1:31–44
 71. Copits BA, Swanson GT (2013) Kainate receptor post-transla-
tional modifications differentially regulate association with 4.1N 
to control activity-dependent receptor endocytosis. J Biol Chem 
288:8952–8965
 72. Pick JE, Khatri L, Sathler MF, Ziff EB (2016) mGluR long-term 
depression regulates GluA2 association with COPII vesicles 
and exit from the endoplasmic reticulum. EMBO J. https://doi.
org/10.15252/embj.201694526
 73. Hanus C, Kochen L, Tom Dieck S, Racine V, Sibarita JB, Schu-
man EM, Ehlers MD (2014) Synaptic control of secretory traf-
ficking in dendrites. Cell Rep 7:1771–1778
 74. Vivithanaporn P, Yan S, Swanson GT (2006) Intracellular traf-
ficking of KA2 kainate receptors mediated by interactions with 
coatomer protein complex I (COPI) and 14–3-3 chaperone sys-
tems. J Biol Chem 281:15475–15484
 75. Nasu-Nishimura Y, Jaffe H, Isaac JT, Roche KW (2010) Differen-
tial regulation of kainate receptor trafficking by phosphorylation 
of distinct sites on GluR6. J Biol Chem 285:2847–2856
 76. Yan D, Yamasaki M, Straub C, Watanabe M, Tomita S (2013) 
Homeostatic control of synaptic transmission by distinct gluta-
mate receptors. Neuron 78:687–699
 77. Straub C, Noam Y, Nomura T, Yamasaki M, Yan D, Fernandes 
HB, Zhang P, Howe JR, Watanabe M, Contractor A, Tomita S 
(2016) Distinct subunit domains govern synaptic stability and 
specificity of the kainate receptor. Cell Rep 16:531–544
 78. Fernandes HB, Catches JS, Petralia RS, Copits BA, Xu J, Rus-
sell TA, Swanson GT, Contractor A (2009) High-affinity kainate 
receptor subunits are necessary for ionotropic but not metabo-
tropic signaling. Neuron 63:818–829
 79. Mulle C, Sailer A, Perez-Otano I, Dickinson-Anson H, Castillo 
PE, Bureau I, Maron C, Gage FH, Mann JR, Bettler B, Heine-
mann SF (1998) Altered synaptic physiology and reduced sus-
ceptibility to kainate- induced seizures in GluR6-deficient mice. 
Nature 392:601–605
 80. Fievre S, Carta M, Chamma I, Labrousse V, Thoumine O, Mulle 
C (2016) Molecular determinants for the strictly compartmental-
ized expression of kainate receptors in CA3 pyramidal cells. Nat 
Commun 7:12738
 81. Coussen F, Normand E, Marchal C, Costet P, Choquet D, Lam-
bert M, Mege RM, Mulle C (2002) Recruitment of the kainate 
receptor subunit glutamate receptor 6 by cadherin/catenin com-
plexes. J Neurosci 22:6426–6436
 82. Garcia EP, Mehta S, Blair LA, Wells DG, Shang J, Fukushima 
T, Fallon JR, Garner CC, Marshall J (1998) SAP90 binds and 
clusters kainate receptors causing incomplete desensitization. 
Neuron 21:727–739
 83. Hirbec H, Francis JC, Lauri SE, Braithwaite SP, Coussen F, 
Mulle C, Dev KK, Coutinho V, Meyer G, Isaac JT, Collingridge 
GL, Henley JM (2003) Rapid and differential regulation of 
AMPA and kainate receptors at hippocampal mossy fibre syn-
apses by PICK1 and GRIP. Neuron 37:625–638
 84. Ng D, Pitcher GM, Szilard RK, Sertie A, Kanisek M, Clapcote 
SJ, Lipina T, Kalia LV, Joo D, McKerlie C, Cortez M, Roder JC, 
Salter MW, McInnes RR (2009) Neto1 is a novel CUB-domain 
NMDA receptor-interacting protein required for synaptic plastic-
ity and learning. PLoS Biol 7:e41
 85. Bowie D, Garcia EP, Marshall J, Traynelis SF, Lange GD (2003) 
Allosteric regulation and spatial distribution of kainate receptors 
bound to ancillary proteins. J Physiol 547:373–385
 86. Suzuki E, Kamiya H (2016) PSD-95 regulates synaptic kain-
ate receptors at mouse hippocampal mossy fiber-CA3 synapses. 
Neurosci Res 107:14–19
 87. Carta M, Opazo P, Veran J, Athane A, Choquet D, Coussen F, 
Mulle C (2013) CaMKII-dependent phosphorylation of GluK5 
mediates plasticity of kainate receptors. EMBO J 32:496–510
 88. Matsuda K (2017) Synapse organization and modulation via C1q 
family proteins and their receptors in the central nervous system. 
Neurosci Res 116:46–53
 89. Matsuda K, Budisantoso T, Mitakidis N, Sugaya Y, Miura E, 
Kakegawa W, Yamasaki M, Konno K, Uchigashima M, Abe M, 
Watanabe I, Kano M, Watanabe M, Sakimura K, Aricescu AR, 
 Neurochemical Research
1 3
Yuzaki M (2016) Transsynaptic modulation of kainate receptor 
functions by C1q-like proteins. Neuron 90:752–767
 90. Zhang W, St-Gelais F, Grabner CP, Trinidad JC, Sumioka A, 
Morimoto-Tomita M, Kim KS, Straub C, Burlingame AL, Howe 
JR, Tomita S (2009) A transmembrane accessory subunit that 
modulates kainate-type glutamate receptors. Neuron 61:385–396
 91. Straub C, Hunt DL, Yamasaki M, Kim KS, Watanabe M, Castillo 
PE, Tomita S (2011) Distinct functions of kainate receptors in 
the brain are determined by the auxiliary subunit Neto1. Nat 
Neurosci 14:866–873
 92. Copits BA, Swanson GT (2012) Dancing partners at the syn-
apse: auxiliary subunits that shape kainate receptor function. 
Nat Rev Neurosci 13:675–686
 93. Tomita S, Castillo PE (2012) Neto1 and Neto2: auxiliary subu-
nits that determine key properties of native kainate receptors. 
J Physiol 590:2217–2223
 94. Howe JR (2014) Modulation of non-NMDA receptor gat-
ing by auxiliary subunits. J Physiol. https://doi.org/10.1113/
jphysiol.2014.273904
 95. Han L, Howe JR, Pickering DS (2016) Neto2 influences on 
kainate receptor pharmacology and function. Basic Clin Phar-
macol Toxicol 119:141–148
 96. Wyeth MS, Pelkey KA, Yuan X, Vargish G, Johnston AD, Hunt 
S, Fang C, Abebe D, Mahadevan V, Fisahn A, Salter MW, 
McInnes RR, Chittajallu R, McBain CJ (2017) Neto auxiliary 
subunits regulate interneuron somatodendritic and presynap-
tic kainate receptors to control network inhibition. Cell Rep 
20:2156–2168
 97. Tang M, Pelkey KA, Ng D, Ivakine E, McBain CJ, Salter MW, 
McInnes RR (2011) Neto1 is an auxiliary subunit of native syn-
aptic kainate receptors. J Neurosci 31:10009–10018
 98. Wyeth MS, Pelkey KA, Petralia RS, Salter MW, McInnes RR, 
McBain CJ (2014) Neto auxiliary protein interactions regulate 
kainate and NMDA receptor subunit localization at mossy fiber-
CA3 pyramidal cell synapses. J Neurosci 34:622–628
 99. Tang M, Ivakine E, Mahadevan V, Salter MW, McInnes RR 
(2012) Neto2 interacts with the scaffolding protein GRIP and 
regulates synaptic abundance of kainate receptors. PLoS ONE 
7:e51433
 100. Palacios-Filardo J, Aller MI, Lerma J (2016) Synaptic targeting 
of kainate receptors. Cereb Cortex 26:1464–1472
 101. Copits BA, Robbins JS, Frausto S, Swanson GT (2011) Synaptic 
targeting and functional modulation of GluK1 kainate receptors 
by the auxiliary neuropilin and tolloid-like (NETO) proteins. J 
Neurosci 31:7334–7340
 102. Sheng N, Shi YS, Nicoll RA (2017) Amino-terminal domains 
of kainate receptors determine the differential dependence on 
Neto auxiliary subunits for trafficking. Proc Natl Acad Sci USA. 
https://doi.org/10.1073/pnas.1619253114
 103. Paternain AV, Herrera MT, Nieto MA, Lerma J (2000) GluR5 
and GluR6 kainate receptor subunits coexist in hippocampal neu-
rons and coassemble to form functional receptors. J Neurosci 
20:196–205
 104. Salinas GD, Blair LA, Needleman LA, Gonzales JD, Chen Y, Li 
M, Singer JD, Marshall J (2006) Actinfilin is a Cul3 substrate 
adaptor, linking GluR6 kainate receptor subunits to the ubiquitin-
proteasome pathway. J Biol Chem 281:40164–40173
 105. Maraschi A, Ciammola A, Folci A, Sassone F, Ronzitti G, Cap-
pelletti G, Silani V, Sato S, Hattori N, Mazzanti M, Chieregatti E, 
Mulle C, Passafaro M, Sassone J (2014) Parkin regulates kainate 
receptors by interacting with the GluK2 subunit. Nat Commun 
5:5182
 106. Pickering DS, Taverna FA, Salter MW, Hampson DR (1995) 
Palmitoylation of the GluR6 kainate receptor. Proc Natl Acad 
Sci USA 92:12090–12094
 107. Wilkinson KA, Konopacki F, Henley JM (2012) Modification 
and movement: phosphorylation and SUMOylation regulate 
endocytosis of GluK2-containing kainate receptors. Commun 
Integr Biol 5:223–226
 108. Wilkinson KA, Henley JM (2010) Mechanisms, regulation and 
consequences of protein SUMOylation. Biochem J 428:133–145
 109. Finley D, Chau V (1991) Ubiquitination. Annu Rev Cell Biol 
7:25–69
 110. Chittajallu R, Vignes M, Dev KK, Barnes JM, Collingridge GL, 
Henley JM (1996) Regulation of glutamate release by presynap-
tic kainate receptors in the hippocampus. Nature 379:78–81
 111. Kamiya H, Ozawa S (1998) Kainate receptor-mediated inhibi-
tion of presynaptic  Ca2+ influx and EPSP in area CA1 of the 
rat hippocampus. J Physiol 509(Pt 3):833–845
 112. Frerking M, Schmitz D, Zhou Q, Johansen J, Nicoll RA (2001) 
Kainate receptors depress excitatory synaptic transmission at 
CA3→CA1 synapses in the hippocampus via a direct presyn-
aptic action. J Neurosci 21:2958–2966
 113. Schmitz D, Mellor J, Frerking M, Nicoll RA (2001) Presyn-
aptic kainate receptors at hippocampal mossy fiber synapses. 
Proc Natl Acad Sci USA 98:11003–11008
 114. Rodriguez-Moreno A, Sihra TS (2011) Metabotropic actions 
of kainate receptors in the control of glutamate release in the 
hippocampus. Adv Exp Med Biol 717:39–48
 115. Andrade-Talavera Y, Duque-Feria P, Sihra TS, Rodriguez-
Moreno A (2013) Pre-synaptic kainate receptor-mediated facil-
itation of glutamate release involves PKA and Ca(2+) -calmo-
dulin at thalamocortical synapses. J Neurochem 126:565–578
 116. Castillo PE, Janz R, Sudhof TC, Tzounopoulos T, Malenka RC, 
Nicoll RA (1997) Rab3A is essential for mossy fibre long-term 
potentiation in the hippocampus. Nature 388:590–593
 117. Melyan Z, Wheal HV, Lancaster B (2002) Metabotropic-medi-
ated kainate receptor regulation of IsAHP and excitability in 
pyramidal cells. Neuron 34:107–114
 118. Melyan Z, Lancaster B, Wheal HV (2004) Metabotropic regu-
lation of intrinsic excitability by synaptic activation of kainate 
receptors. J Neurosci 24:4530–4534
 119. Rodriguez-Moreno A, Lerma J (1998) Kainate receptor modu-
lation of GABA release involves a metabotropic function. Neu-
ron 20:1211–1218
 120. Jiang L, Kang D, Kang J (2015) Potentiation of tonic GABAe-
rgic inhibition by activation of postsynaptic kainate receptors. 
Neuroscience 298:448–454
 121. Chamma I, Chevy Q, Poncer JC, Levi S (2012) Role of the 
neuronal K-Cl co-transporter KCC2 in inhibitory and excita-
tory neurotransmission. Front Cell Neurosci 6:5
 122. Woodin MA, Ganguly K, Poo MM (2003) Coincident pre- 
and postsynaptic activity modifies GABAergic synapses 
by postsynaptic changes in Cl- transporter activity. Neuron 
39:807–820
 123. Tyzio R, Nardou R, Ferrari DC, Tsintsadze T, Shahrokhi A, 
Eftekhari S, Khalilov I, Tsintsadze V, Brouchoud C, Chazal 
G, Lemonnier E, Lozovaya N, Burnashev N, Ben-Ari Y 
(2014) Oxytocin-mediated GABA inhibition during delivery 
attenuates autism pathogenesis in rodent offspring. Science 
343:675–679
 124. Woo NS, Lu J, England R, McClellan R, Dufour S, Mount DB, 
Deutch AY, Lovinger DM, Delpire E (2002) Hyperexcitability 
and epilepsy associated with disruption of the mouse neuronal-
specific K-Cl cotransporter gene. Hippocampus 12:258–268
 125. Ivakine EA, Acton BA, Mahadevan V, Ormond J, Tang M, Pres-
sey JC, Huang MY, Ng D, Delpire E, Salter MW, Woodin MA, 
McInnes RR (2013) Neto2 is a KCC2 interacting protein required 
for neuronal Cl- regulation in hippocampal neurons. Proc Natl 
Acad Sci USA 110:3561–3566
Neurochemical Research 
1 3
 126. Mahadevan V, Pressey JC, Acton BA, Uvarov P, Huang MY, 
Chevrier J, Puchalski A, Li CM, Ivakine EA, Airaksinen MS, 
Delpire E, McInnes RR, Woodin MA (2014) Kainate receptors 
coexist in a functional complex with KCC2 and regulate chloride 
homeostasis in hippocampal neurons. Cell Rep 7:1762–1770
 127. Matute C (2011) Therapeutic potential of kainate receptors. CNS 
Neurosci Ther 17:661–669
 128. Yuan H, Low CM, Moody OA, Jenkins A, Traynelis SF (2015) 
Ionotropic GABA and glutamate receptor mutations and human 
neurologic diseases. Mol Pharmacol 88:203–217
 129. Crepel V, Mulle C (2015) Physiopathology of kainate receptors 
in epilepsy. Curr Opin Pharmacol 20:83–88
 130. Tauck DL, Nadler JV (1985) Evidence of functional mossy fiber 
sprouting in hippocampal formation of kainic acid-treated rats. 
J Neurosci 5:1016–1022
 131. Represa A, Trembley E, Ben-Ari Y (1987) Kainate binding sites 
in the hippocampal mossy fibres: localization and plasticity. Neu-
roscience 20:739–748
 132. Epsztein J, Represa A, Jorquera I, Ben-Ari Y, Crepel V (2005) 
Recurrent mossy fibers establish aberrant kainate receptor-oper-
ated synapses on granule cells from epileptic rats. J Neurosci 
25:8229–8239
 133. Peret A, Christie LA, Ouedraogo DW, Gorlewicz A, Epsztein 
J, Mulle C, Crepel V (2014) Contribution of aberrant GluK2-
containing kainate receptors to chronic seizures in temporal lobe 
epilepsy. Cell Rep 8:347–354
 134. Yu LM, Polygalov D, Wintzer ME, Chiang MC, McHugh TJ 
(2016) CA3 synaptic silencing attenuates kainic acid-induced 
seizures and hippocampal network oscillations. eNeuro. https://
doi.org/10.1523/ENEURO.0003-16.2016
 135. Guzman YF, Ramsey K, Stolz JR, Craig DW, Huentelman MJ, 
Narayanan V, Swanson GT (2017) A gain-of-function mutation 
in the GRIK2 gene causes neurodevelopmental deficits. Neurol 
Genet 3:e129
 136. Lanore F, Labrousse VF, Szabo Z, Normand E, Blanchet C, 
Mulle C (2012) Deficits in morphofunctional maturation of hip-
pocampal mossy fiber synapses in a mouse model of intellectual 
disability. J Neurosci 32:17882–17893
 137. Micheau J, Vimeney A, Normand E, Mulle C, Riedel G (2014) 
Impaired hippocampus-dependent spatial flexibility and sociabil-
ity represent autism-like phenotypes in GluK2 mice. Hippocam-
pus 24:1059–1069
 138. Griswold AJ, Ma D, Cukier HN, Nations LD, Schmidt MA, 
Chung RH, Jaworski JM, Salyakina D, Konidari I, Whitehead 
PL, Wright HH, Abramson RK, Williams SM, Menon R, Mar-
tin ER, Haines JL, Gilbert JR, Cuccaro ML, Pericak-Vance MA 
(2012) Evaluation of copy number variations reveals novel can-
didate genes in autism spectrum disorder-associated pathways. 
Hum Mol Genet 21:3513–3523
 139. Aller MI, Pecoraro V, Paternain AV, Canals S, Lerma J (2015) 
Increased dosage of high-affinity kainate receptor gene grik4 
alters synaptic transmission and reproduces autism spectrum 
disorders features. J Neurosci 35:13619–13628
 140. Milanesi E, Bonvicini C, Congiu C, Bortolomasi M, Gainelli 
G, Gennarelli M, Minelli A (2015) The role of GRIK4 gene in 
treatment-resistant depression. Genet Res 97:e14
 141. Pickard BS, Malloy MP, Christoforou A, Thomson PA, Evans 
KL, Morris SW, Hampson M, Porteous DJ, Blackwood DH, Muir 
WJ (2006) Cytogenetic and genetic evidence supports a role for 
the kainate-type glutamate receptor gene, GRIK4, in schizophre-
nia and bipolar disorder. Mol Psychiatry 11:847–857
 142. Xu J, Marshall JJ, Fernandes HB, Nomura T, Copits BA, Procissi 
D, Mori S, Wang L, Zhu Y, Swanson GT, Contractor A (2017) 
Complete disruption of the kainate receptor gene family results 
in corticostriatal dysfunction in mice. Cell Rep 18:1848–1857
